Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Observational 2

Sponsor

Cancer Type

CNS 2

Conditions

Central Nervous System Neoplasms 2Central Nervous System Diseases 2Carcinoma, Hepatocellular 2Breast Neoplasms 2Brain Neoplasms 2Lymphoma 1Liver Neoplasms 1

Interventions

gadobenic acid 2Cancer Vaccines 2Adjuvants, Immunologic 2veliparib 1tipifarnib 1interferon gamma-1b 1glutathione pegylated liposomal doxorubicin 1gadoteridol 1Trastuzumab 1Temozolomide 1Sodium Chloride 1Oncolytic Virotherapy 1Interferon-gamma 1Immunotherapy 1Dexmedetomidine 1Craniotomy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Central Nervous System Diseases × gadobenic acid × Clear all
NCT03147989 2018-07-18

Retrospective Study of MRI With MULTIHANCE at 0.10 and 0.05 mmol/Kg Dose in CNS Patients

Bracco Diagnostics, Inc

Completed
352 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

NCT02291822 2016-07-19

Retrospective Study of MRI in Pediatric Patients

Bracco Diagnostics, Inc

Completed
90 enrolled
CNS

Central Nervous System Diseases, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡